nodes	percent_of_prediction	percent_of_DWPC	metapath
Conivaptan—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.194	0.463	CbGbCtD
Conivaptan—CYP3A4—Progesterone—uterine cancer	0.129	0.306	CbGbCtD
Conivaptan—CYP3A4—Etoposide—uterine cancer	0.0577	0.137	CbGbCtD
Conivaptan—CYP3A4—Doxorubicin—uterine cancer	0.0393	0.0935	CbGbCtD
Conivaptan—Phlebitis—Carboplatin—uterine cancer	0.0159	0.0274	CcSEcCtD
Conivaptan—Electrocardiogram ST segment depression—Epirubicin—uterine cancer	0.0125	0.0216	CcSEcCtD
Conivaptan—Electrocardiogram ST segment depression—Doxorubicin—uterine cancer	0.0116	0.02	CcSEcCtD
Conivaptan—Sepsis—Medroxyprogesterone Acetate—uterine cancer	0.00779	0.0134	CcSEcCtD
Conivaptan—Thirst—Progesterone—uterine cancer	0.00755	0.013	CcSEcCtD
Conivaptan—Thirst—Medroxyprogesterone Acetate—uterine cancer	0.00685	0.0118	CcSEcCtD
Conivaptan—Infection—Carboplatin—uterine cancer	0.00668	0.0115	CcSEcCtD
Conivaptan—Hypoglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.00668	0.0115	CcSEcCtD
Conivaptan—Sepsis—Dactinomycin—uterine cancer	0.00607	0.0105	CcSEcCtD
Conivaptan—Orthostatic hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00595	0.0103	CcSEcCtD
Conivaptan—Hypokalaemia—Medroxyprogesterone Acetate—uterine cancer	0.00593	0.0102	CcSEcCtD
Conivaptan—Phlebitis—Dactinomycin—uterine cancer	0.0059	0.0102	CcSEcCtD
Conivaptan—Pain—Carboplatin—uterine cancer	0.00575	0.00993	CcSEcCtD
Conivaptan—Pollakiuria—Progesterone—uterine cancer	0.00574	0.0099	CcSEcCtD
Conivaptan—Hyperglycaemia—Progesterone—uterine cancer	0.00561	0.00967	CcSEcCtD
Conivaptan—Pneumonia—Progesterone—uterine cancer	0.00557	0.00962	CcSEcCtD
Conivaptan—Infestation NOS—Progesterone—uterine cancer	0.00554	0.00956	CcSEcCtD
Conivaptan—Infestation—Progesterone—uterine cancer	0.00554	0.00956	CcSEcCtD
Conivaptan—Urinary tract infection—Progesterone—uterine cancer	0.00539	0.00929	CcSEcCtD
Conivaptan—Body temperature increased—Carboplatin—uterine cancer	0.00532	0.00918	CcSEcCtD
Conivaptan—Pollakiuria—Medroxyprogesterone Acetate—uterine cancer	0.0052	0.00898	CcSEcCtD
Conivaptan—Hyperglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.00508	0.00876	CcSEcCtD
Conivaptan—Infestation NOS—Medroxyprogesterone Acetate—uterine cancer	0.00502	0.00866	CcSEcCtD
Conivaptan—Infestation—Medroxyprogesterone Acetate—uterine cancer	0.00502	0.00866	CcSEcCtD
Conivaptan—Urinary tract disorder—Progesterone—uterine cancer	0.00491	0.00848	CcSEcCtD
Conivaptan—Oedema peripheral—Progesterone—uterine cancer	0.0049	0.00845	CcSEcCtD
Conivaptan—Urinary tract infection—Medroxyprogesterone Acetate—uterine cancer	0.00488	0.00842	CcSEcCtD
Conivaptan—Urethral disorder—Progesterone—uterine cancer	0.00488	0.00841	CcSEcCtD
Conivaptan—Candida infection—Etoposide—uterine cancer	0.00484	0.00835	CcSEcCtD
Conivaptan—Cardiac disorder—Progesterone—uterine cancer	0.00462	0.00796	CcSEcCtD
Conivaptan—Angiopathy—Progesterone—uterine cancer	0.00451	0.00779	CcSEcCtD
Conivaptan—Mediastinal disorder—Progesterone—uterine cancer	0.00448	0.00773	CcSEcCtD
Conivaptan—Oral candidiasis—Epirubicin—uterine cancer	0.00447	0.00771	CcSEcCtD
Conivaptan—Hypomagnesaemia—Epirubicin—uterine cancer	0.00447	0.00771	CcSEcCtD
Conivaptan—Urinary tract disorder—Medroxyprogesterone Acetate—uterine cancer	0.00445	0.00768	CcSEcCtD
Conivaptan—Oedema peripheral—Medroxyprogesterone Acetate—uterine cancer	0.00444	0.00766	CcSEcCtD
Conivaptan—Urethral disorder—Medroxyprogesterone Acetate—uterine cancer	0.00442	0.00762	CcSEcCtD
Conivaptan—Sepsis—Etoposide—uterine cancer	0.0044	0.00759	CcSEcCtD
Conivaptan—Mental disorder—Progesterone—uterine cancer	0.00436	0.00752	CcSEcCtD
Conivaptan—Erythema—Progesterone—uterine cancer	0.00433	0.00747	CcSEcCtD
Conivaptan—Malnutrition—Progesterone—uterine cancer	0.00433	0.00747	CcSEcCtD
Conivaptan—Phlebitis—Etoposide—uterine cancer	0.00427	0.00737	CcSEcCtD
Conivaptan—Cardiac disorder—Medroxyprogesterone Acetate—uterine cancer	0.00418	0.00722	CcSEcCtD
Conivaptan—Hypomagnesaemia—Doxorubicin—uterine cancer	0.00414	0.00714	CcSEcCtD
Conivaptan—Oral candidiasis—Doxorubicin—uterine cancer	0.00414	0.00714	CcSEcCtD
Conivaptan—Angiopathy—Medroxyprogesterone Acetate—uterine cancer	0.00409	0.00706	CcSEcCtD
Conivaptan—Mediastinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00406	0.00701	CcSEcCtD
Conivaptan—Anaemia—Progesterone—uterine cancer	0.004	0.00691	CcSEcCtD
Conivaptan—Mental disorder—Medroxyprogesterone Acetate—uterine cancer	0.00395	0.00681	CcSEcCtD
Conivaptan—Pneumonia—Dactinomycin—uterine cancer	0.00394	0.0068	CcSEcCtD
Conivaptan—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.00392	0.00677	CcSEcCtD
Conivaptan—Malnutrition—Medroxyprogesterone Acetate—uterine cancer	0.00392	0.00677	CcSEcCtD
Conivaptan—Cardiac failure—Etoposide—uterine cancer	0.00377	0.0065	CcSEcCtD
Conivaptan—Hypertension—Progesterone—uterine cancer	0.00374	0.00645	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00366	0.00632	CcSEcCtD
Conivaptan—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00363	0.00626	CcSEcCtD
Conivaptan—Dry mouth—Progesterone—uterine cancer	0.00361	0.00622	CcSEcCtD
Conivaptan—Confusional state—Progesterone—uterine cancer	0.00356	0.00615	CcSEcCtD
Conivaptan—Infection—Progesterone—uterine cancer	0.00351	0.00606	CcSEcCtD
Conivaptan—Nervous system disorder—Progesterone—uterine cancer	0.00347	0.00598	CcSEcCtD
Conivaptan—Skin disorder—Progesterone—uterine cancer	0.00343	0.00592	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00332	0.00572	CcSEcCtD
Conivaptan—Hypotension—Progesterone—uterine cancer	0.0033	0.0057	CcSEcCtD
Conivaptan—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.00327	0.00564	CcSEcCtD
Conivaptan—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00323	0.00557	CcSEcCtD
Conivaptan—Insomnia—Progesterone—uterine cancer	0.0032	0.00551	CcSEcCtD
Conivaptan—Infection—Medroxyprogesterone Acetate—uterine cancer	0.00318	0.00549	CcSEcCtD
Conivaptan—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00314	0.00542	CcSEcCtD
Conivaptan—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00311	0.00537	CcSEcCtD
Conivaptan—Erythema—Dactinomycin—uterine cancer	0.00306	0.00528	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Progesterone—uterine cancer	0.00305	0.00526	CcSEcCtD
Conivaptan—Constipation—Progesterone—uterine cancer	0.00302	0.00521	CcSEcCtD
Conivaptan—Pain—Progesterone—uterine cancer	0.00302	0.00521	CcSEcCtD
Conivaptan—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00299	0.00516	CcSEcCtD
Conivaptan—Feeling abnormal—Progesterone—uterine cancer	0.00291	0.00502	CcSEcCtD
Conivaptan—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.0029	0.005	CcSEcCtD
Conivaptan—Pneumonia—Etoposide—uterine cancer	0.00285	0.00492	CcSEcCtD
Conivaptan—Infestation NOS—Etoposide—uterine cancer	0.00283	0.00489	CcSEcCtD
Conivaptan—Infestation—Etoposide—uterine cancer	0.00283	0.00489	CcSEcCtD
Conivaptan—Anaemia—Dactinomycin—uterine cancer	0.00283	0.00488	CcSEcCtD
Conivaptan—Body temperature increased—Progesterone—uterine cancer	0.00279	0.00482	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00276	0.00477	CcSEcCtD
Conivaptan—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00274	0.00472	CcSEcCtD
Conivaptan—Candida infection—Epirubicin—uterine cancer	0.00271	0.00468	CcSEcCtD
Conivaptan—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00264	0.00455	CcSEcCtD
Conivaptan—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00253	0.00437	CcSEcCtD
Conivaptan—Urinary tract disorder—Etoposide—uterine cancer	0.00251	0.00434	CcSEcCtD
Conivaptan—Candida infection—Doxorubicin—uterine cancer	0.00251	0.00433	CcSEcCtD
Conivaptan—Pruritus—Progesterone—uterine cancer	0.0025	0.00431	CcSEcCtD
Conivaptan—Urethral disorder—Etoposide—uterine cancer	0.00249	0.0043	CcSEcCtD
Conivaptan—Infection—Dactinomycin—uterine cancer	0.00248	0.00428	CcSEcCtD
Conivaptan—Sepsis—Epirubicin—uterine cancer	0.00246	0.00425	CcSEcCtD
Conivaptan—Diarrhoea—Progesterone—uterine cancer	0.00242	0.00417	CcSEcCtD
Conivaptan—Phlebitis—Epirubicin—uterine cancer	0.00239	0.00413	CcSEcCtD
Conivaptan—Cardiac disorder—Etoposide—uterine cancer	0.00236	0.00407	CcSEcCtD
Conivaptan—Angiopathy—Etoposide—uterine cancer	0.00231	0.00398	CcSEcCtD
Conivaptan—Mediastinal disorder—Etoposide—uterine cancer	0.00229	0.00396	CcSEcCtD
Conivaptan—Sepsis—Doxorubicin—uterine cancer	0.00228	0.00393	CcSEcCtD
Conivaptan—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00227	0.00391	CcSEcCtD
Conivaptan—Vomiting—Progesterone—uterine cancer	0.00225	0.00388	CcSEcCtD
Conivaptan—Phlebitis—Doxorubicin—uterine cancer	0.00221	0.00382	CcSEcCtD
Conivaptan—Headache—Progesterone—uterine cancer	0.00221	0.00382	CcSEcCtD
Conivaptan—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00219	0.00378	CcSEcCtD
Conivaptan—Pain—Dactinomycin—uterine cancer	0.00214	0.00369	CcSEcCtD
Conivaptan—Hypoglycaemia—Epirubicin—uterine cancer	0.00211	0.00365	CcSEcCtD
Conivaptan—Cardiac failure—Epirubicin—uterine cancer	0.00211	0.00365	CcSEcCtD
Conivaptan—Nausea—Progesterone—uterine cancer	0.0021	0.00362	CcSEcCtD
Conivaptan—Hyponatraemia—Epirubicin—uterine cancer	0.00207	0.00357	CcSEcCtD
Conivaptan—Feeling abnormal—Dactinomycin—uterine cancer	0.00206	0.00355	CcSEcCtD
Conivaptan—Anaemia—Etoposide—uterine cancer	0.00205	0.00353	CcSEcCtD
Conivaptan—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00204	0.00351	CcSEcCtD
Conivaptan—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00201	0.00346	CcSEcCtD
Conivaptan—Body temperature increased—Dactinomycin—uterine cancer	0.00197	0.00341	CcSEcCtD
Conivaptan—Hypoglycaemia—Doxorubicin—uterine cancer	0.00195	0.00337	CcSEcCtD
Conivaptan—Cardiac failure—Doxorubicin—uterine cancer	0.00195	0.00337	CcSEcCtD
Conivaptan—Dehydration—Epirubicin—uterine cancer	0.00192	0.00331	CcSEcCtD
Conivaptan—Hyponatraemia—Doxorubicin—uterine cancer	0.00192	0.0033	CcSEcCtD
Conivaptan—Hypertension—Etoposide—uterine cancer	0.00191	0.0033	CcSEcCtD
Conivaptan—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.0019	0.00328	CcSEcCtD
Conivaptan—Orthostatic hypotension—Epirubicin—uterine cancer	0.00188	0.00325	CcSEcCtD
Conivaptan—Hypokalaemia—Epirubicin—uterine cancer	0.00188	0.00324	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00187	0.00323	CcSEcCtD
Conivaptan—Confusional state—Etoposide—uterine cancer	0.00182	0.00314	CcSEcCtD
Conivaptan—Infection—Etoposide—uterine cancer	0.0018	0.0031	CcSEcCtD
Conivaptan—Dehydration—Doxorubicin—uterine cancer	0.00177	0.00306	CcSEcCtD
Conivaptan—Skin disorder—Etoposide—uterine cancer	0.00176	0.00303	CcSEcCtD
Conivaptan—Orthostatic hypotension—Doxorubicin—uterine cancer	0.00174	0.00301	CcSEcCtD
Conivaptan—Hypokalaemia—Doxorubicin—uterine cancer	0.00174	0.003	CcSEcCtD
Conivaptan—Diarrhoea—Dactinomycin—uterine cancer	0.00171	0.00295	CcSEcCtD
Conivaptan—Hypotension—Etoposide—uterine cancer	0.00169	0.00291	CcSEcCtD
Conivaptan—Pollakiuria—Epirubicin—uterine cancer	0.00165	0.00284	CcSEcCtD
Conivaptan—Hyperglycaemia—Epirubicin—uterine cancer	0.00161	0.00277	CcSEcCtD
Conivaptan—Pneumonia—Epirubicin—uterine cancer	0.0016	0.00276	CcSEcCtD
Conivaptan—Infestation NOS—Epirubicin—uterine cancer	0.00159	0.00274	CcSEcCtD
Conivaptan—Infestation—Epirubicin—uterine cancer	0.00159	0.00274	CcSEcCtD
Conivaptan—Vomiting—Dactinomycin—uterine cancer	0.00159	0.00274	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Etoposide—uterine cancer	0.00156	0.00269	CcSEcCtD
Conivaptan—Pain—Etoposide—uterine cancer	0.00155	0.00267	CcSEcCtD
Conivaptan—Constipation—Etoposide—uterine cancer	0.00155	0.00267	CcSEcCtD
Conivaptan—Urinary tract infection—Epirubicin—uterine cancer	0.00154	0.00266	CcSEcCtD
Conivaptan—Pollakiuria—Doxorubicin—uterine cancer	0.00152	0.00263	CcSEcCtD
Conivaptan—Haematuria—Epirubicin—uterine cancer	0.00151	0.00261	CcSEcCtD
Conivaptan—Feeling abnormal—Etoposide—uterine cancer	0.00149	0.00257	CcSEcCtD
Conivaptan—Hyperglycaemia—Doxorubicin—uterine cancer	0.00149	0.00257	CcSEcCtD
Conivaptan—Nausea—Dactinomycin—uterine cancer	0.00148	0.00256	CcSEcCtD
Conivaptan—Pneumonia—Doxorubicin—uterine cancer	0.00148	0.00255	CcSEcCtD
Conivaptan—Infestation NOS—Doxorubicin—uterine cancer	0.00147	0.00254	CcSEcCtD
Conivaptan—Infestation—Doxorubicin—uterine cancer	0.00147	0.00254	CcSEcCtD
Conivaptan—Body temperature increased—Etoposide—uterine cancer	0.00143	0.00247	CcSEcCtD
Conivaptan—Urinary tract infection—Doxorubicin—uterine cancer	0.00143	0.00247	CcSEcCtD
Conivaptan—Urinary tract disorder—Epirubicin—uterine cancer	0.00141	0.00243	CcSEcCtD
Conivaptan—Oedema peripheral—Epirubicin—uterine cancer	0.00141	0.00242	CcSEcCtD
Conivaptan—Haematuria—Doxorubicin—uterine cancer	0.0014	0.00242	CcSEcCtD
Conivaptan—Urethral disorder—Epirubicin—uterine cancer	0.0014	0.00241	CcSEcCtD
Conivaptan—Cardiac disorder—Epirubicin—uterine cancer	0.00132	0.00228	CcSEcCtD
Conivaptan—Urinary tract disorder—Doxorubicin—uterine cancer	0.0013	0.00225	CcSEcCtD
Conivaptan—Oedema peripheral—Doxorubicin—uterine cancer	0.0013	0.00224	CcSEcCtD
Conivaptan—Angiopathy—Epirubicin—uterine cancer	0.00129	0.00223	CcSEcCtD
Conivaptan—Urethral disorder—Doxorubicin—uterine cancer	0.00129	0.00223	CcSEcCtD
Conivaptan—Mediastinal disorder—Epirubicin—uterine cancer	0.00129	0.00222	CcSEcCtD
Conivaptan—Pruritus—Etoposide—uterine cancer	0.00128	0.00221	CcSEcCtD
Conivaptan—Mental disorder—Epirubicin—uterine cancer	0.00125	0.00216	CcSEcCtD
Conivaptan—Malnutrition—Epirubicin—uterine cancer	0.00124	0.00214	CcSEcCtD
Conivaptan—Erythema—Epirubicin—uterine cancer	0.00124	0.00214	CcSEcCtD
Conivaptan—Diarrhoea—Etoposide—uterine cancer	0.00124	0.00213	CcSEcCtD
Conivaptan—Cardiac disorder—Doxorubicin—uterine cancer	0.00122	0.00211	CcSEcCtD
Conivaptan—Angiopathy—Doxorubicin—uterine cancer	0.0012	0.00207	CcSEcCtD
Conivaptan—Mediastinal disorder—Doxorubicin—uterine cancer	0.00119	0.00205	CcSEcCtD
Conivaptan—Mental disorder—Doxorubicin—uterine cancer	0.00116	0.00199	CcSEcCtD
Conivaptan—Vomiting—Etoposide—uterine cancer	0.00115	0.00198	CcSEcCtD
Conivaptan—Malnutrition—Doxorubicin—uterine cancer	0.00115	0.00198	CcSEcCtD
Conivaptan—Erythema—Doxorubicin—uterine cancer	0.00115	0.00198	CcSEcCtD
Conivaptan—Anaemia—Epirubicin—uterine cancer	0.00115	0.00198	CcSEcCtD
Conivaptan—Headache—Etoposide—uterine cancer	0.00113	0.00195	CcSEcCtD
Conivaptan—Nausea—Etoposide—uterine cancer	0.00107	0.00185	CcSEcCtD
Conivaptan—Hypertension—Epirubicin—uterine cancer	0.00107	0.00185	CcSEcCtD
Conivaptan—Anaemia—Doxorubicin—uterine cancer	0.00106	0.00183	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.00105	0.00181	CcSEcCtD
Conivaptan—Dry mouth—Epirubicin—uterine cancer	0.00103	0.00178	CcSEcCtD
Conivaptan—Confusional state—Epirubicin—uterine cancer	0.00102	0.00176	CcSEcCtD
Conivaptan—Infection—Epirubicin—uterine cancer	0.00101	0.00174	CcSEcCtD
Conivaptan—Nervous system disorder—Epirubicin—uterine cancer	0.000994	0.00171	CcSEcCtD
Conivaptan—Hypertension—Doxorubicin—uterine cancer	0.000992	0.00171	CcSEcCtD
Conivaptan—Skin disorder—Epirubicin—uterine cancer	0.000984	0.0017	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000971	0.00168	CcSEcCtD
Conivaptan—Dry mouth—Doxorubicin—uterine cancer	0.000957	0.00165	CcSEcCtD
Conivaptan—Hypotension—Epirubicin—uterine cancer	0.000947	0.00163	CcSEcCtD
Conivaptan—Confusional state—Doxorubicin—uterine cancer	0.000945	0.00163	CcSEcCtD
Conivaptan—Infection—Doxorubicin—uterine cancer	0.000931	0.00161	CcSEcCtD
Conivaptan—Nervous system disorder—Doxorubicin—uterine cancer	0.000919	0.00159	CcSEcCtD
Conivaptan—Insomnia—Epirubicin—uterine cancer	0.000916	0.00158	CcSEcCtD
Conivaptan—Skin disorder—Doxorubicin—uterine cancer	0.000911	0.00157	CcSEcCtD
Conivaptan—Hypotension—Doxorubicin—uterine cancer	0.000876	0.00151	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000875	0.00151	CcSEcCtD
Conivaptan—Constipation—Epirubicin—uterine cancer	0.000867	0.0015	CcSEcCtD
Conivaptan—Pain—Epirubicin—uterine cancer	0.000867	0.0015	CcSEcCtD
Conivaptan—Insomnia—Doxorubicin—uterine cancer	0.000848	0.00146	CcSEcCtD
Conivaptan—Feeling abnormal—Epirubicin—uterine cancer	0.000835	0.00144	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000809	0.0014	CcSEcCtD
Conivaptan—Pain—Doxorubicin—uterine cancer	0.000802	0.00138	CcSEcCtD
Conivaptan—Constipation—Doxorubicin—uterine cancer	0.000802	0.00138	CcSEcCtD
Conivaptan—Body temperature increased—Epirubicin—uterine cancer	0.000801	0.00138	CcSEcCtD
Conivaptan—Feeling abnormal—Doxorubicin—uterine cancer	0.000773	0.00133	CcSEcCtD
Conivaptan—Body temperature increased—Doxorubicin—uterine cancer	0.000741	0.00128	CcSEcCtD
Conivaptan—Pruritus—Epirubicin—uterine cancer	0.000717	0.00124	CcSEcCtD
Conivaptan—Diarrhoea—Epirubicin—uterine cancer	0.000693	0.0012	CcSEcCtD
Conivaptan—Pruritus—Doxorubicin—uterine cancer	0.000663	0.00114	CcSEcCtD
Conivaptan—Vomiting—Epirubicin—uterine cancer	0.000644	0.00111	CcSEcCtD
Conivaptan—Diarrhoea—Doxorubicin—uterine cancer	0.000641	0.00111	CcSEcCtD
Conivaptan—Headache—Epirubicin—uterine cancer	0.000635	0.0011	CcSEcCtD
Conivaptan—Nausea—Epirubicin—uterine cancer	0.000602	0.00104	CcSEcCtD
Conivaptan—Vomiting—Doxorubicin—uterine cancer	0.000596	0.00103	CcSEcCtD
Conivaptan—Headache—Doxorubicin—uterine cancer	0.000587	0.00101	CcSEcCtD
Conivaptan—Nausea—Doxorubicin—uterine cancer	0.000557	0.000961	CcSEcCtD
